skip to primary navigationskip to content

Jonathon Pines to head up Cancer Biology at ICR

Dr Jonathon Pines, Senior Group Leader and Cancer Research UK Senior Research Fellow at the Gurdon Institute, will take up the post of Head of Division of Cancer Biology at the Institute of Cancer Research (ICR) in London from 1st October 2015.

Read more

Innovative A-T research project described in video

Professor Steve Jackson describes his lab's newest project probing variations in the genetic disease Ataxia-Telangiectasia, in this video from funding charity Action for A-T.

Read more

Cell competition eliminates unhealthy cells

Eugenia Piddini’s group, with the help of Ben Simons, have studied what happens when the health of some cells in a population is sub-optimal, and find that these cells are eliminated from a tissue by competition from healthy cells. This mechanism could help delay the insurgence of disease and ageing.

Read more

The Gurdon Institute Seminar Series is back!

The new season opens on 6th October 2015 with Melina Schuh from the MRC LMB, Cambridge, with her talk "New insights into aneuploidy in mammalian oocytes".

Read more

Tony Kouzarides launches Therapeutics Consortium and Milner Therapeutics Institute

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge, with the aim of developing and studying designer medicines for globally important diseases. In 2018 the Consortium will operate from the new Milner Therapeutics Institute on the Cambridge Biomedical Campus.

Read more

About us

The Gurdon Institute is funded by the Wellcome Trust and Cancer Research UK to study the biology of normal development and of cancer and other diseases.